Two Sigma Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $571K | Buy |
+3,610
| New | +$488K | 0.05% | 520 |
|
|
2025
Q4 | – | Sell |
-4,935
| Closed | -$494K | – | 2088 |
|
|
2025
Q3 | $494K | Sell |
4,935
-12,608
| -72% | -$1.14M | 0.07% | 369 |
|
|
2025
Q2 | $1.45M | Buy |
17,543
+4,960
| +39% | +$396K | 0.18% | 129 |
|
|
2025
Q1 | $1.02M | Buy |
12,583
+4,472
| +55% | +$400K | 0.15% | 151 |
|
|
2024
Q4 | $730K | Sell |
8,111
-27,854
| -77% | -$2.7M | 0.1% | 231 |
|
|
2024
Q3 | $3.55M | Buy |
35,965
+9,273
| +35% | +$911K | 0.06% | 366 |
|
|
2024
Q2 | $2.47M | Buy |
26,692
+6,000
| +29% | +$538K | 0.03% | 616 |
|
|
2024
Q1 | $1.96M | Buy |
20,692
+9,196
| +80% | +$853K | 0.02% | 763 |
|
|
2023
Q4 | $1.03M | Sell |
11,496
-60,494
| -84% | -$4.49M | 0.01% | 1029 |
|
|
2023
Q3 | $5.26M | Buy |
71,990
+61,825
| +608% | +$4.94M | 0.06% | 351 |
|
|
2023
Q2 | $846K | Sell |
10,165
-1,120
| -10% | -$93.7K | 0.01% | 1073 |
|
|
2023
Q1 | $860K | Buy |
+11,285
| New | +$936K | 0.02% | 916 |
|
|
2022
Q3 | – | Sell |
-10,742
| Closed | -$906K | – | 3171 |
|
|
2022
Q2 | $798K | Sell |
10,742
-11,440
| -52% | -$859K | 0.03% | 643 |
|
|
2022
Q1 | $1.99M | Buy |
+22,182
| New | +$2.05M | 0.07% | 355 |
|
|
2021
Q3 | – | Sell |
-1,744
| Closed | -$225K | – | 2019 |
|
|
2021
Q2 | $236K | Buy |
+1,744
| New | +$229K | 0.01% | 1182 |
|
|
2021
Q1 | – | Sell |
-6,482
| Closed | -$913K | – | 1830 |
|
|
2020
Q4 | $913K | Buy |
6,482
+2,388
| +58% | +$306K | 0.02% | 434 |
|
|
2020
Q3 | $456K | Buy |
+4,094
| New | +$459K | 0.01% | 649 |
|
|
2020
Q2 | – | Sell |
-16,103
| Closed | -$1.59M | – | 1807 |
|
|
2020
Q1 | $1.25M | Buy |
+16,103
| New | +$1.43M | 0.03% | 341 |
|
|
2019
Q1 | – | Sell |
-11,594
| Closed | -$986K | – | 2524 |
|
|
2018
Q4 | $832K | Buy |
11,594
+3,998
| +53% | +$322K | 0.01% | 724 |
|
|
2018
Q3 | $728K | Buy |
+7,596
| New | +$736K | ﹤0.01% | 1190 |
|
|
2018
Q1 | – | Sell |
-105,562
| Closed | -$9.64M | – | 3000 |
|
|
2017
Q4 | $8.96M | Buy |
105,562
+66,085
| +167% | +$5.54M | 0.24% | 67 |
|
|
2017
Q3 | $3.42M | Buy |
+39,477
| New | +$3.16M | 0.31% | 78 |
|
|
2017
Q2 | – | Sell |
-147,327
| Closed | -$10.2M | – | 1216 |
|
|
2017
Q1 | $10.2M | Buy |
+147,327
| New | +$9.89M | 2% | 6 |
|
|
2016
Q2 | – | Sell |
-16,745
| Closed | -$865K | – | 532 |
|
|
2016
Q1 | $865K | Buy |
16,745
+3,958
| +31% | +$206K | 1.11% | 8 |
|
|
2015
Q4 | $896K | Buy |
12,787
+5,431
| +74% | +$370K | 1.08% | 15 |
|
|
2015
Q3 | $458K | Buy |
+7,356
| New | +$580K | 0.72% | 32 |
|
|
2015
Q2 | – | Sell |
-26,781
| Closed | -$2.01M | – | 274 |
|
|
2015
Q1 | $2.01M | Buy |
+26,781
| New | +$1.87M | 2.07% | 10 |
|
Other funds holding XBI
JFG
Two Sigma Securities's XBI Position: Q2 2026 in Review
Two Sigma Securities opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 3,610 shares worth $571K. The stake represents 0.05% of the portfolio and ranks #520 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in XBI as recently as Q3 2025.
Two Sigma Securities first reported a position in XBI in Q1 2015 and has held it in 27 quarters since. The position peaked at $10.2M in Q1 2017. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Two Sigma Securities held 3,610 shares of State Street SPDR S&P Biotech ETF worth $571K as of Q2 2026.
- State Street SPDR S&P Biotech ETF was a new Two Sigma Securities position in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 0.05% of Two Sigma Securities's portfolio in Q2 2026, its #520 holding.
- Two Sigma Securities first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and has held it in 27 quarters since.
- Two Sigma Securities's State Street SPDR S&P Biotech ETF position peaked at $10.2M in Q1 2017.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.